APACMed 2020: Stryker Is Exercising New Innovation Muscles During COVID-19
Executive Summary
Many changes have come about for the orthopedic innovator Stryker as a result of the pandemic, says group CEO Kevin Lobo. The most important relates to methods of engagement with customers.
You may also be interested in...
Stryker Sees ‘V-Shape’ Recovery In Third Quarter
Led by the Mako surgical robot, Stryker’s third-quarter sales exceeded Wall Street analysts’ expectations as it prepares to complete the $4bn acquisition of Wright Medical.
Stryker Doubles Down On Novadaq To Boost Medsurg
Stryker is set to expand its surgical offerings after signing a $701m deal to buy Novadaq Technologies, a leading developer of fluorescence surgical imaging technology. The acquisition price is a 96% premium over Novadaq's June 16 closing price, which, according to analysts, is believed to be due to a competitive bidding process for the company.
Post-Brexit MHRA Will Embrace Medtech ‘Innovation Pull’ In The UK
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: